Cytokinetics: Q4 Earnings Insights

Cytokinetics: Q4 Earnings Insights

Cytokinetics CYTK reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Cytokinetics beat estimated earnings by 57.14%, reporting an EPS of $-0.36 versus an estimate of $-0.84.

Revenue was up $48.88 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.19 which was followed by a 6.27% increase in the share price the next day.

Here's a look at Cytokinetics's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.76 -0.65 -0.58  
EPS Actual -0.95 -0.86 -0.66 -0.62
Revenue Estimate 6.42M 5.45M 6.58M 8.56M
Revenue Actual 5.44M 2.84M 6.55M 6.72M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings